Suppr超能文献

铁死亡的机制。

Mechanisms of ferroptosis.

作者信息

Cao Jennifer Yinuo, Dixon Scott J

机构信息

Department of Biology, Stanford University, 337 Campus Dr., Stanford, CA, 94305, USA.

出版信息

Cell Mol Life Sci. 2016 Jun;73(11-12):2195-209. doi: 10.1007/s00018-016-2194-1. Epub 2016 Apr 5.

Abstract

Ferroptosis is a non-apoptotic form of cell death that can be triggered by small molecules or conditions that inhibit glutathione biosynthesis or the glutathione-dependent antioxidant enzyme glutathione peroxidase 4 (GPX4). This lethal process is defined by the iron-dependent accumulation of lipid reactive oxygen species and depletion of plasma membrane polyunsaturated fatty acids. Cancer cells with high level RAS-RAF-MEK pathway activity or p53 expression may be sensitized to this process. Conversely, a number of small molecule inhibitors of ferroptosis have been identified, including ferrostatin-1 and liproxstatin-1, which can block pathological cell death events in brain, kidney and other tissues. Recent work has identified a number of genes required for ferroptosis, including those involved in lipid and amino acid metabolism. Outstanding questions include the relationship between ferroptosis and other forms of cell death, and whether activation or inhibition of ferroptosis can be exploited to achieve desirable therapeutic ends.

摘要

铁死亡是一种非凋亡形式的细胞死亡,可由抑制谷胱甘肽生物合成或谷胱甘肽依赖性抗氧化酶谷胱甘肽过氧化物酶4(GPX4)的小分子或条件引发。这个致死过程的定义是脂质活性氧的铁依赖性积累和质膜多不饱和脂肪酸的消耗。具有高水平RAS-RAF-MEK通路活性或p53表达的癌细胞可能对这个过程敏感。相反,已经鉴定出许多铁死亡的小分子抑制剂,包括铁抑素-1和脂氧素他汀-1,它们可以阻断脑、肾和其他组织中的病理性细胞死亡事件。最近的研究确定了许多铁死亡所需的基因,包括那些参与脂质和氨基酸代谢的基因。悬而未决的问题包括铁死亡与其他形式细胞死亡之间的关系,以及激活或抑制铁死亡是否可用于实现理想的治疗目的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/968c/11108442/085cfe4a7d65/18_2016_2194_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验